NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > Modernising Medical Microbiology and Big Infection Diagnostics > Study increases understanding of lung microbiome in severe asthma patients

Study increases understanding of lung microbiome in severe asthma patients

11 September 2024 · Listed under Modernising Medical Microbiology and Big Infection Diagnostics, Respiratory Medicine

Respiratory researchers in Oxford have discovered a link between potentially pathogenic bacteria and airways inflammation in severe asthma.

Microscopic image of Haemophilus influenzae bacteria
Haemophilus influenzae bacteria (Photo: Alain Grillet for Sanofi Pasteur, via Flickr)

The team, who are supported by the NIHR Oxford Biomedical Research Centre (BRC), used long-read genome sequencing on sputum and nasal lavage samples from people with asthma to study the airway microbiome.

Until now, the specific species in the airway microbiome have not been identified; neither have the relationships between these species and mucosal immune responses in neutrophilic asthma, a severe type of asthma caused by an accumulation of white blood cells in the lungs.

The study was led by Professor Timothy Hinks, of the University of Oxford’s Nuffield Department of Medicine and an Oxford BRC Senior Research Fellow. He explained: “We have used a fairly new genome sequencing technique, produced by Oxford Nanopore Technologies, which allowed us to identify the bacteria at individual species level, where older technologies were less precise.

“It has allowed us to achieve the best description to date of the microbiome in the lung in the world’s most common respiratory disease: asthma.”

The paper was published in Allergy, the official journal of the European Academy of Allergy and Clinical Immunology. 

The team found that the microbiome in healthy people and those with mild asthma had similar microbial diversity in their samples. But 23 percent of the microbiomes in people with severe asthma were dominated by one of three respiratory pathogens: haemophilus influenzae, moraxella catarrhalis or streptococcus pneumoniae.

Professor Tim Hinks

“We found that these three pathogens – which in our group we call the three musketeers –  manage to survive where very few other bacteria can. The lung is usually very efficient at clearing out bacteria, so each of these bugs has evolved ways of surviving and persisting in the human airways. H. influenzae, in particular, only infects humans, no other species, so it’s intriguing to know how it does this,” Professor Hinks (pictured left) explained.

“By integrating the bacteria we found with markers of the immune response, we have acquired new insights into how these pathogens manage to evade the immune system.” Early indications suggest that Haemophilus induces IL-10, an anti-inflammatory molecule, and this is perhaps helping it to evade immune detection.

← New bronchoscopy capability expands capacity for respiratory and vaccine trials
Oxford researchers awarded £11m to address antimicrobial resistance →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre